BioSpace News Archive

AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today reported financial results for the second quarter ended June 30, 2022 and provided a business update.

Eagle Pharmaceuticals, Inc., and Enalare Therapeutics Inc announced an agreement for Eagle to make an equity investment of $25 million in Enalare, a clinical-stage privately held biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions.

Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2022 financial results.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the second quarter of 2022 and recent business achievements.

Lyra Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2022, and highlighted recent accomplishments.

Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee will hold a meeting on September 22, 2022, to review data supporting the biologics license application (BLA) for RBX2660, a microbiota-based live biotherapeutic studied for its potential to reduce recurrent C. difficile infection (CDI) after antibiotic treatment.

908 Devices today announces that it has completed the acquisition of privately-held TRACE Analytics GmbH, based in Braunschweig, Germany, a provider of on-line analysis and sampling systems for biotech applications.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company” or “we” or “our”) today announced its second-quarter 2022 financial results.

KemPharm, Inc. today announced the appointment of Nichol Ochsner to the role of Vice President, Investor Relations and Corporate Communications.

ImmPACT Bio USA , Inc. today announced the appointment of Vikram Lamba, M.B.M. as chief financial officer (CFO) and head of business development.